THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆
COA-Backed Quality — if a delivered item is damaged, defective, or incorrect, contact us within 48 hours and we'll make it right per our Refund & Return Policy.
For Research Use Only. Not intended for human consumption, veterinary use, or any clinical application, sold exclusively for laboratory and in-vitro research. By purchasing, you confirm you are a qualified researcher.
Secure Checkout
VISAMastercardAMEXDiscover SSL Secured
Category
Blends
Purity
High purity (research grade)
Storage
Refrigerate at 2–8°C
Form
Lyophilized powder
Shipping
Ships in 24–48 business hours · discreet
Overview
About CJC-1295 No DAC + Ipamorelin 10mg
CJC-1295 No DAC + Ipamorelin 10mg is a dual-peptide research blend pairing two well-characterized reference compounds used to study the growth hormone axis. CJC-1295 without DAC is a modified growth hormone-releasing hormone (GHRH) analog that researchers use to probe GHRH-receptor signaling, while Ipamorelin is a selective growth hormone secretagogue that acts as a ghrelin-receptor (GHS-R) agonist. Formulating the two in a single vial gives laboratories a convenient tool for investigating how the GHRH and ghrelin pathways interact in vitro.
Because each peptide engages a distinct receptor, this blend is frequently used as a model system for exploring complementary secretagogue mechanisms, receptor-level pharmacology, and the pulsatile dynamics of growth hormone release in cell-culture and preclinical settings. Ipamorelin's noted selectivity makes it a useful comparator for studies that aim to isolate GH-specific responses from broader endocrine effects.
Key research areas
Pulsatile growth hormone secretion and its regulation in in-vitro pituitary or cell-culture models
Comparative GHRH-receptor versus ghrelin-receptor (GHS-R) signaling
Synergistic secretagogue activity when GHRH-analog and ghrelin-mimetic pathways are co-stimulated
Metabolic and anabolic signaling in preclinical research frameworks
Receptor-binding and structure-activity investigations of peptide secretagogues
Specifications
Amount: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin (10mg total per vial)
Form: Lyophilized white powder
Storage: Refrigerate at 2–8°C; keep lyophilized material protected from light and moisture
Composition: Two-peptide research blend — CJC-1295 without DAC (GHRH analog) and Ipamorelin (GHS-R agonist)
Quality: Third-party tested for identity and purity; a Certificate of Analysis is available on request
Echo Peptides supplies this blend as a research-grade reference material sourced from qualified production channels. This product is intended strictly for laboratory and in-vitro research use only — it is not for human or veterinary use, and not for diagnostic or therapeutic purposes.
Regulatory notice. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease, and not for human or veterinary use. Sold exclusively for laboratory and in-vitro research by qualified professionals — always follow proper laboratory safety protocols.
This vial
Working with the 10mg vial
This vial contains 10 mg of lyophilized material. Reconstitution does not change that mass — it changes the volume it occupies — so the concentration you end up with is set entirely by how much diluent you add.
Diluent added
Concentration
Concentration
Molarity
1 mL
10 mg/mL
10000 µg/mL
—
2 mL
5 mg/mL
5000 µg/mL
—
3 mL
3.33 mg/mL
3333 µg/mL
—
5 mL
2 mg/mL
2000 µg/mL
—
Molarity is not shown because a verified molecular weight for this compound is not yet published.
Figures are unit conversions for handling reference material in vitro. Nothing here is a dose or a protocol.
Frequently Asked Questions
What makes CJC-1295 No DAC and Ipamorelin a useful blend for research?
The two peptides engage different receptors — CJC-1295 (No DAC) acts as a GHRH analog while Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist. Combining them lets researchers study how the GHRH and ghrelin secretagogue pathways interact in cell-culture and preclinical models of growth hormone release.
What does "No DAC" mean in CJC-1295 No DAC?
DAC refers to a Drug Affinity Complex moiety that extends a peptide's circulating half-life. The "No DAC" designation indicates this CJC-1295 variant lacks that modification, giving it shorter-acting GHRH-analog characteristics that researchers often prefer when modeling pulsatile, rather than sustained, signaling in vitro.
How is this blend supplied and stored?
Each vial contains 5mg of CJC-1295 (No DAC) plus 5mg of Ipamorelin (10mg total) as a lyophilized white powder. It should be refrigerated at 2–8°C and kept protected from light and moisture. It is third-party tested for identity and purity, with a Certificate of Analysis available on request.
